Toho Holdings Company Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Toho Holdings Company Limited with three other
drug stores in Asia:
Vital KSK Holdings Incorporation
sales of 581.08 billion Japanese Yen [US$5.16 billion]
of which 95%
was Pharmaceuticals Sales),
Hokuyaku Takeyama Holdings, Inc
(228.71 billion Japanese Yen [US$2.03 billion]
of which 70%
was Pharmaceutical Business), and
Suzuken Co., Ltd.
(2.13 trillion Japanese Yen [US$18.89 billion]
of which 93%
was Pharmaceutical Wholesale Business).
During the year ended March of 2017, sales at
Toho Holdings Company Limited were ¥1.23 trillion (US$10.93 billion).
decrease of 5.9%
versus 2016, when the company's sales were ¥1.31 trillion.
Contributing to the drop in overall sales was the 39.4% decline
in Institutional Support for Clinical Trial, from ¥531.00 million to ¥322.00 million.
There were also decreases in sales in
Pharmaceutical Wholesale Business (down 6.0% to ¥1.13 trillion)
Dispensing Pharmacy Business (down 4.3% to ¥95.46 billion)
However, these declines were partially offset by the increase in sales of
Information Equipment Sales (up 9.9% to ¥1.33 billion)